Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study

Arthritis Research and Therapy

Volumn 14, Issue 4, 2012, Pages

  McAdams DeMarco, Mara A ^a,b   Maynard, Janet W ^b   Coresh, Josef ^a   Baer, Alan N ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; URIC ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; ANEMIA; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GOUT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; RACE; RISK FACTOR; URIC ACID BLOOD LEVEL; COHORT ANALYSIS; DEMOGRAPHY; FOLLOW UP; HEALTH SURVEY; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY;

ANEMIA; ATHEROSCLEROSIS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GOUT; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 84865059023     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4026     Document Type: Article

References (49)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008, 58:26-35. 10.1002/art.23176, 3266664, 18163497.
2. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987, 82:421-426. 10.1016/0002-9343(87)90441-4, 3826098.
3. Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H. Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum 2010, 62:1069-1076. 10.1002/art.27338, 20131266.
4. DeMarco McAdams MA, Maynard JW, Huizinga MM, Baer AN, Kottgen A, Gelber AC, Coresh J. Obesity and younger age at gout onset in a community-based cohort. Arthritis Care Res 2011, 63:1108-1114.
5. Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005, 165:742-748. 10.1001/archinte.165.7.742, 15824292.
6. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004, 350:1093-1103. 10.1056/NEJMoa035700, 15014182.
7. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006, 54:2688-2696. 10.1002/art.22014, 16871533.
8. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007, 116:894-900. 10.1161/CIRCULATIONAHA.107.703389, 17698728.
9. Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008, 168:1104-1110. 10.1001/archinte.168.10.1104, 18504339.
10. Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002, 40:27-33. 10.1016/S0735-1097(02)01938-1, 12103252.
11. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2006, 151:492-500. 10.1016/j.ahj.2005.03.055, 16442920.
12. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995, 47:884-890. 10.1038/ki.1995.132, 7752588.
13. Penninx BW, Pahor M, Woodman RC, Guralnik JM. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci 2006, 61:474-479. 10.1093/gerona/61.5.474, 16720744.
14. Salive ME, Cornoni-Huntley J, Guralnik JM, Phillips CL, Wallace RB, Ostfeld AM, Cohen HJ. Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J Am Geriatr Soc 1992, 40:489-496.
15. Riva E, Tettamanti M, Mosconi P, Apolone G, Gandini F, Nobili A, Tallone MV, Detoma P, Giacomin A, Clerico M, Tempia P, Guala A, Lucca U. Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica 2009, 94:22-28. 10.3324/haematol.13449, 2625429, 19001283.
16. Nissenson AR, Goodnough LT, Dubois RW. Anemia: not just an innocent bystander?. Arch Intern Med 2003, 163:1400-1404. 10.1001/archinte.163.12.1400, 12824088.
17. Bergamini C, Cicoira M, Rossi A, Vassanelli C. Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Failure 2009, 11:444-452.
18. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989, 129:687-702.
19. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 1989, 61:15-19.
20. World Health Organization Worldwide Prevalence of Anaemia 1993-2005 2008, Geneva: World Health Organization, World Health Organization.
21. McAdams MA, Maynard JW, Baer AN, Köttgen A, Clipp S, Coresh J, AC G. Reliability and validity of the self-report of physician-diagnosed gout in the Campaign Against Cancer and Heart Disease (CLUE II) and Atherosclerosis Risk in the Community (ARIC) Cohorts. J Rheum 2011, 38:135-141. 10.3899/jrheum.100418, 3285109, 21123328.
22. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612. 2763564, 19414839.
23. Eckfeldt JH, Chambless LE, Shen YL. Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med 1994, 118:496-500.
24. Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 2006, 8(Suppl 1):S2. 10.1186/ar1907, 3226075, 16899106.
25. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008, 67:960-966. 2564789, 17981913.
26. Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med 2010, 28:204-217. 10.1055/s-0030-1251477, 20414843.
27. Cavusoglu E, Chopra V, Gupta A, Clark LT, Eng C, Marmur JD. Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. Am J Cardiol 2006, 98:580-584. 10.1016/j.amjcard.2006.03.031, 16923440.
28. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005, 111:2042-2049. 10.1161/01.CIR.0000162477.70955.5F, 15824203.
29. Arant CB, Wessel TR, Olson MB, Bairey Merz CN, Sopko G, Rogers WJ, Sharaf BL, Reis SE, Smith KM, Johnson BD, Handberg E, Mankad D, Pepine CJ. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol 2004, 43:2009-2014. 10.1016/j.jacc.2004.01.038, 15172405.
30. Zoppini G, Targher G, Chonchol M, Negri C, Stoico V, Pichiri I, Lippi G, Muggeo M, Bonora E. Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. Atherosclerosis 2010, 210:575-580. 10.1016/j.atherosclerosis.2009.12.008, 20031129.
31. He SW, Wang LX. The impact of anemia on the prognosis of chronic heart failure: a meta-analysis and systemic review. Congest Heart Fail 2009, 15:123-130. 10.1111/j.1751-7133.2008.00030.x, 19522961.
32. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int 2003, 64:610-615. 10.1046/j.1523-1755.2003.00109.x, 12846757.
33. Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR. Impact of anemia on hospitalization and mortality in older adults. Blood 2006, 107:3841-3846. 10.1182/blood-2005-10-4308, 16403909.
34. Ma JZ, Ebben J, Xia H, Collins AJ. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999, 10:610-619.
35. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE. Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int 2006, 69:560-564. 10.1038/sj.ki.5000105, 16395253.
36. Vlagopoulos PT, Tighiouart H, Weiner DE, Griffith J, Pettitt D, Salem DN, Levey AS, Sarnak MJ. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol 2005, 16:3403-3410. 10.1681/ASN.2005030226, 16162813.
37. Oliva EN, Schey C, Hutchings AS. A review of anemia as a cardiovascular risk factor in patients with myelodysplastic syndromes. Am J Blood Res 2011, 1:160-166. 3301424, 22432077.
38. Eckardt KU. Managing a fateful alliance: anaemia and cardiovascular outcomes. Nephrol Dial Transplant 2005, 20(Suppl 6):vi16-20.
39. Yoo JH, Maeng HY, Sun YK, Kim YA, Park DW, Park TS, Lee ST, Choi JR. Oxidative status in iron-deficiency anemia. J Clin Lab Anal 2009, 23:319-323. 10.1002/jcla.20335, 19774625.
40. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 1986, 235:747-754. 1146751, 3753442.
41. Ghio AJ, Kennedy TP, Rao G, Cooke CL, Miller MJ, Hoidal JR. Complexation of iron cation by sodium urate crystals and gouty inflammation. Arch Biochem Biophys 1994, 313:215-221. 10.1006/abbi.1994.1379, 8080265.
42. Ghio AJ, Ford ES, Kennedy TP, Hoidal JR. The association between serum ferritin and uric acid in humans. Free Rad Res 2005, 39:337-342.
43. Facchini FS. Near-iron deficiency-induced remission of gouty arthritis. Rheumatology (Oxford) 2003, 42:1550-1555.
44. Gutman AB, Yu TF. Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med 1957, 23:600-622. 10.1016/0002-9343(57)90231-0, 13469831.
45. Robinson BE. Epidemiology of chronic kidney disease and anemia. J Am Med Dir Assoc 2006, 7:S3-6. quiz S17-21, 10.1016/j.jamda.2006.09.004, 17098633.
46. Zakai NA, McClure LA, Prineas R, Howard G, McClellan W, Holmes CE, Newsome BB, Warnock DG, Audhya P, Cushman M. Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary Study. Am J Epidemiol 2009, 169:355-364. 2720717, 19066309.
47. Yip R, Dallman PR. The roles of inflammation and iron deficiency as causes of anemia. Am J Clin Nutr 1988, 48:1295-1300.
48. Busso N, So A. Mechanisms of inflammation in gout. Arthritis Res Ther 2010, 12:206. 10.1186/ar2952, 2888190, 20441605.
49. Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum 1995, 38:628-632. 10.1002/art.1780380508, 7748218.